ITMI931418A1 - Enantiomeri farmacologicamente attivi - Google Patents

Enantiomeri farmacologicamente attivi

Info

Publication number
ITMI931418A1
ITMI931418A1 IT93MI001418A ITMI931418A ITMI931418A1 IT MI931418 A1 ITMI931418 A1 IT MI931418A1 IT 93MI001418 A IT93MI001418 A IT 93MI001418A IT MI931418 A ITMI931418 A IT MI931418A IT MI931418 A1 ITMI931418 A1 IT MI931418A1
Authority
IT
Italy
Prior art keywords
pharmacologically active
active enantiomers
formula
enantiomers
alk
Prior art date
Application number
IT93MI001418A
Other languages
English (en)
Inventor
Leandro Baiocchi
Valerio Cioli
Original Assignee
Angelini Francesco Ist Ricerca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Francesco Ist Ricerca filed Critical Angelini Francesco Ist Ricerca
Publication of ITMI931418A0 publication Critical patent/ITMI931418A0/it
Priority to IT93MI001418A priority Critical patent/IT1268414B1/it
Priority to KR1019950705994A priority patent/KR100306018B1/ko
Priority to PL94312419A priority patent/PL181831B1/pl
Priority to SI9430110T priority patent/SI0707587T1/xx
Priority to BR9406996A priority patent/BR9406996A/pt
Priority to AT94919660T priority patent/ATE158796T1/de
Priority to ROA200100015A priority patent/RO121031B1/ro
Priority to JP07503250A priority patent/JP3096065B2/ja
Priority to HU9503876A priority patent/HU221631B1/hu
Priority to ES94919660T priority patent/ES2111309T3/es
Priority to NZ268014A priority patent/NZ268014A/xx
Priority to RO95-02315A priority patent/RO116899B1/ro
Priority to CZ19953485A priority patent/CZ289526B6/cs
Priority to GEAP19943025A priority patent/GEP19991791B/en
Priority to SK1664-95A priority patent/SK281060B6/sk
Priority to US08/564,276 priority patent/US5741907A/en
Priority to AU70729/94A priority patent/AU689478B2/en
Priority to DK94919660.4T priority patent/DK0707587T3/da
Priority to CA002166470A priority patent/CA2166470C/en
Priority to UA96010331A priority patent/UA53607C2/uk
Priority to DE69405999T priority patent/DE69405999T2/de
Priority to EP94919660A priority patent/EP0707587B1/en
Priority to CN94193226A priority patent/CN1046281C/zh
Priority to PCT/EP1994/002061 priority patent/WO1995001354A1/en
Priority to RU96104371A priority patent/RU2128180C1/ru
Priority to ZA944570A priority patent/ZA944570B/xx
Publication of ITMI931418A1 publication Critical patent/ITMI931418A1/it
Priority to FI956334A priority patent/FI111943B/fi
Priority to NO955345A priority patent/NO305957B1/no
Priority to LVP-96-17A priority patent/LV11546B/en
Priority to BG100331A priority patent/BG61815B1/bg
Publication of IT1268414B1 publication Critical patent/IT1268414B1/it
Application granted granted Critical
Priority to US08/995,988 priority patent/US5817815A/en
Priority to GR970403452T priority patent/GR3025806T3/el
Priority to US09/076,845 priority patent/US5973150A/en
Priority to AU69041/98A priority patent/AU718075B2/en
Priority to CNB98116661XA priority patent/CN1136201C/zh
Priority to CNB981166601A priority patent/CN1136200C/zh
Priority to HK99103799A priority patent/HK1018781A1/xx
Priority to HK99103792A priority patent/HK1018777A1/xx
Priority to CZ20004132A priority patent/CZ292867B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Enantiomeri farmacologicamente attivi di formula (FORMULA IA) in cui Alk è alchile a 1-3C,loro sali con acidi fisiologicamente accettabili, metodo per prepararli e composizioni farmaceutiche che li contengono.
IT93MI001418A 1993-07-01 1993-07-01 Enantiomeri farmacologicamente attivi IT1268414B1 (it)

Priority Applications (39)

Application Number Priority Date Filing Date Title
IT93MI001418A IT1268414B1 (it) 1993-07-01 1993-07-01 Enantiomeri farmacologicamente attivi
DE69405999T DE69405999T2 (de) 1993-07-01 1994-06-21 Pharmazeutisch wirksame enantiomere
CN94193226A CN1046281C (zh) 1993-07-01 1994-06-21 药理活性的对映体及其制备方法
SI9430110T SI0707587T1 (en) 1993-07-01 1994-06-21 Pharmacologically active enantiomers
EP94919660A EP0707587B1 (en) 1993-07-01 1994-06-21 Pharmacologically active enantiomers
AT94919660T ATE158796T1 (de) 1993-07-01 1994-06-21 Pharmazeutisch wirksame enantiomere
PCT/EP1994/002061 WO1995001354A1 (en) 1993-07-01 1994-06-21 Pharmacologically active enantiomers
JP07503250A JP3096065B2 (ja) 1993-07-01 1994-06-21 医薬的に活性な鏡像体
PL94312419A PL181831B1 (pl) 1993-07-01 1994-06-21 Farmakologicznie aktywne enancjomery PL PL PL PL PL
ES94919660T ES2111309T3 (es) 1993-07-01 1994-06-21 Enantiomeros farmacologicamente activos.
NZ268014A NZ268014A (en) 1993-07-01 1994-06-21 1,2,4-triazol [4,3-a]pyridin-3(2h)ones; enantiomers of such compounds and a method for their preparation
RO95-02315A RO116899B1 (ro) 1993-07-01 1994-06-21 DERIVATI DE 1,2,4-TRIAZOL[4,3-a]-PIRIDINONA SI PROCEDEU PENTRU PREPARAREA ACESTORA
CZ19953485A CZ289526B6 (cs) 1993-07-01 1994-06-21 (S) nebo (R) Enantiomer piperazinylové sloučeniny a způsob jeho přípravy
GEAP19943025A GEP19991791B (en) 1993-07-01 1994-06-21 Pharmacologically Active Enantiomers and Process for its Production
SK1664-95A SK281060B6 (sk) 1993-07-01 1994-06-21 Farmakologicky účinné enantioméry, spôsob ich prípravy, medziprodukty tohto postupu
US08/564,276 US5741907A (en) 1993-07-01 1994-06-21 Pharmacologically active enantiomers
AU70729/94A AU689478B2 (en) 1993-07-01 1994-06-21 Pharmacologically active enantiomers of triazolone compounds
DK94919660.4T DK0707587T3 (da) 1993-07-01 1994-06-21 Farmakologisk aktive enantiomerer
CA002166470A CA2166470C (en) 1993-07-01 1994-06-21 Pharmacologically active enantiomers
UA96010331A UA53607C2 (uk) 1993-07-01 1994-06-21 Фармакологічно активні енантіомери, спосіб їх отримання, проміжна сполука для їх отримання та спосіб її отримання
KR1019950705994A KR100306018B1 (ko) 1993-07-01 1994-06-21 약리학적 활성을 갖는 에난티오머
BR9406996A BR9406996A (pt) 1993-07-01 1994-06-21 Enanciômero processo para preparar o mesmo processo para ciclizar um composto e composto intermediário
HU9503876A HU221631B1 (hu) 1993-07-01 1994-06-21 Gyógyászatilag aktív 1,2,4-triazo [4,3-a]piridin enantiomerek és eljárás ezek, valamint piperazin-intermedierek előállítására
ROA200100015A RO121031B1 (ro) 1993-07-01 1994-06-21 Derivat de 3-clorfenil-piperazinonă şi procedeude preparare a acestuia
RU96104371A RU2128180C1 (ru) 1993-07-01 1994-06-21 (s)- или (r)-энантиомеры, способы их получения, промежуточный продукт
ZA944570A ZA944570B (en) 1993-07-01 1994-06-24 Pharmacologically active enantiomers
FI956334A FI111943B (fi) 1993-07-01 1995-12-29 Analogiamenetelmä terapeuttisesti käyttökelpoisen enantiomeerisen yhdisteen valmistamiseksi, joka on (S)- tai (R)-2-[3-[4-(3-kloorifenyyli)-1-(2-alkyyli)-piperatsinyyli]propyyli]-1,2,4-triatsolo[4,3-a]pyridin-3-(2H)-oni, ja välituotteet
NO955345A NO305957B1 (no) 1993-07-01 1995-12-29 Farmakologisk aktive enantiomerer
LVP-96-17A LV11546B (en) 1993-07-01 1996-01-26 Pharmacologically active enantiomers
BG100331A BG61815B1 (bg) 1993-07-01 1996-02-01 Фармакологично активни енантиомери
US08/995,988 US5817815A (en) 1993-07-01 1997-12-22 Pharmacologically active enantiomers
GR970403452T GR3025806T3 (en) 1993-07-01 1997-12-30 Pharmacologically active enantiomers
US09/076,845 US5973150A (en) 1993-07-01 1998-05-13 Pharmacologically active enantiomers
AU69041/98A AU718075B2 (en) 1993-07-01 1998-05-27 Intermediates for the preparation of pharmacologically active enantiomers of triazolone compounds
CNB98116661XA CN1136201C (zh) 1993-07-01 1998-07-29 药理活性的对映体及其制备方法
CNB981166601A CN1136200C (zh) 1993-07-01 1998-07-29 药理活性的对映体及其制备方法
HK99103799A HK1018781A1 (en) 1993-07-01 1999-09-02 Pharmacologically active enantiomers
HK99103792A HK1018777A1 (en) 1993-07-01 1999-09-02 Pharmacologically active enantiomers
CZ20004132A CZ292867B6 (cs) 1993-07-01 2000-11-07 Způsob cyklizace anilinových derivátů

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI001418A IT1268414B1 (it) 1993-07-01 1993-07-01 Enantiomeri farmacologicamente attivi

Publications (3)

Publication Number Publication Date
ITMI931418A0 ITMI931418A0 (it) 1993-07-01
ITMI931418A1 true ITMI931418A1 (it) 1995-01-01
IT1268414B1 IT1268414B1 (it) 1997-02-27

Family

ID=11366510

Family Applications (1)

Application Number Title Priority Date Filing Date
IT93MI001418A IT1268414B1 (it) 1993-07-01 1993-07-01 Enantiomeri farmacologicamente attivi

Country Status (30)

Country Link
US (3) US5741907A (it)
EP (1) EP0707587B1 (it)
JP (1) JP3096065B2 (it)
KR (1) KR100306018B1 (it)
CN (3) CN1046281C (it)
AT (1) ATE158796T1 (it)
AU (1) AU689478B2 (it)
BG (1) BG61815B1 (it)
BR (1) BR9406996A (it)
CA (1) CA2166470C (it)
CZ (1) CZ289526B6 (it)
DE (1) DE69405999T2 (it)
DK (1) DK0707587T3 (it)
ES (1) ES2111309T3 (it)
FI (1) FI111943B (it)
GE (1) GEP19991791B (it)
GR (1) GR3025806T3 (it)
HK (2) HK1018781A1 (it)
HU (1) HU221631B1 (it)
IT (1) IT1268414B1 (it)
LV (1) LV11546B (it)
NO (1) NO305957B1 (it)
NZ (1) NZ268014A (it)
PL (1) PL181831B1 (it)
RO (2) RO121031B1 (it)
RU (1) RU2128180C1 (it)
SK (1) SK281060B6 (it)
UA (1) UA53607C2 (it)
WO (1) WO1995001354A1 (it)
ZA (1) ZA944570B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1268414B1 (it) * 1993-07-01 1997-02-27 Angelini Francesco Ist Ricerca Enantiomeri farmacologicamente attivi
JP2009018992A (ja) * 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
RU2706700C1 (ru) 2019-09-24 2019-11-20 Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" Фармацевтическая композиция для коррекции поведения кошек и собак в стрессовых ситуациях

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3365453A (en) * 1963-10-28 1968-01-23 Sterling Drug Inc 1-phenyl-4-lower-alkyl-2-piperazinones
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
US5303837A (en) * 1991-03-05 1994-04-19 Portola Packaging, Inc. One-piece fitment and plug with tamper-evident band
US5739334A (en) * 1992-01-17 1998-04-14 Istituto Ricerca Francesco Angelini S.P.A. Alkyl derivatives of trazodone with CNS activity
IT1258790B (it) * 1992-01-17 1996-02-29 Angelini Francesco Ist Ricerca Alchil derivati del trazodone
IT1268414B1 (it) * 1993-07-01 1997-02-27 Angelini Francesco Ist Ricerca Enantiomeri farmacologicamente attivi
US5399765A (en) * 1994-05-23 1995-03-21 Sepracor, Inc. Enantioselective preparation of optically pure albuterol

Also Published As

Publication number Publication date
RO116899B1 (ro) 2001-07-30
EP0707587A1 (en) 1996-04-24
BG100331A (bg) 1996-09-30
UA53607C2 (uk) 2003-02-17
EP0707587B1 (en) 1997-10-01
FI111943B (fi) 2003-10-15
CZ289526B6 (cs) 2002-02-13
LV11546B (en) 1997-02-20
JP3096065B2 (ja) 2000-10-10
SK281060B6 (sk) 2000-11-07
PL181831B1 (pl) 2001-09-28
GEP19991791B (en) 1999-10-05
AU689478B2 (en) 1998-04-02
CN1129939A (zh) 1996-08-28
HUT73230A (en) 1996-07-29
GR3025806T3 (en) 1998-03-31
NO955345L (no) 1996-02-29
RO121031B1 (ro) 2006-11-30
CN1215052A (zh) 1999-04-28
CN1136201C (zh) 2004-01-28
DK0707587T3 (da) 1998-05-11
DE69405999D1 (de) 1997-11-06
SK166495A3 (en) 1996-09-04
IT1268414B1 (it) 1997-02-27
HK1018777A1 (en) 2000-01-07
HK1018781A1 (en) 2000-01-07
ATE158796T1 (de) 1997-10-15
FI956334A0 (fi) 1995-12-29
ITMI931418A0 (it) 1993-07-01
BG61815B1 (bg) 1998-06-30
PL312419A1 (en) 1996-04-15
WO1995001354A1 (en) 1995-01-12
ES2111309T3 (es) 1998-03-01
NO955345D0 (no) 1995-12-29
LV11546A (lv) 1996-10-20
FI956334A (fi) 1996-02-19
JPH08512036A (ja) 1996-12-17
CA2166470A1 (en) 1995-01-12
KR100306018B1 (ko) 2001-11-30
HU221631B1 (hu) 2002-12-28
NO305957B1 (no) 1999-08-23
US5817815A (en) 1998-10-06
US5973150A (en) 1999-10-26
RU2128180C1 (ru) 1999-03-27
US5741907A (en) 1998-04-21
NZ268014A (en) 1997-08-22
AU7072994A (en) 1995-01-24
CN1136200C (zh) 2004-01-28
CN1215053A (zh) 1999-04-28
BR9406996A (pt) 1996-09-10
HU9503876D0 (en) 1996-02-28
CZ348595A3 (en) 1996-04-17
ZA944570B (en) 1995-04-11
DE69405999T2 (de) 1998-04-16
CA2166470C (en) 2001-12-18
CN1046281C (zh) 1999-11-10

Similar Documents

Publication Publication Date Title
NZ509239A (en) 2-(4-(N-salicyloyl)aminophenyl)propionic acid useful as a carrier in compositions for delivering active agents
ATE132150T1 (de) 3-alkenyl-1-azabicyclo(3.2.0)hept-2-en-2- carbonsäure-verbindungen
DE68917023T2 (de) 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen.
DK0524587T3 (da) Terapeutiske sammensætninger til intranasal indgivelse indeholdende Ketorolac R
ATE107306T1 (de) 3-pyrrolidinylthio-1-azabicyclo (3.2.0)hept-2-en- 2-carbonsäure-verbindungen.
UY24625A1 (es) Derivados de la 4-hidroxi-piperidina
PT928788E (pt) Compostos farmaceuticamente activos
KR870700067A (ko) 피리도(2,3-d)-피리미딘 유도체
EA200200489A1 (ru) Новые соединения бензотиадиазина, способ их получения и содержащие их фармацевтические композиции
MY135646A (en) Indolyl derivatives
GB1187259A (en) New Aminoalkyl Esters of 2-Anilino-Nicotinic Acids and process for their manufacture
ITMI931418A1 (it) Enantiomeri farmacologicamente attivi
TW200503732A (en) Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and derivatives and methods of use thereof
IE891578L (en) Compounds with central analgesic activity, process for their¹preparation and pharmaceutical compositions containing them
DE3668888D1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
DK0643061T3 (da) Nye cephalosporin-antibitotika
EA200000374A2 (ru) Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции
ITMI913448A0 (it) Sali stabili dell'acido (+)-(1r,2s)-2-[ [n-(2-idrossilammino-2-ossoetil)-n-metilammino! carbonil! cicloesan-1-carbossilico, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
GB1245155A (en) NOVEL 5-SUBSTITUTED-gamma-CARBOLINE DERIVATIVES AND THE SALTS THEREOF
GB1246727A (en) Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids
IE860294L (en) Pharmaceutical comprising aminopropoxyindole derivatives
WO1995006473A3 (en) Medical use of polysulfonic acid compound
ES2004255A6 (es) Procedimiento de preparar compuestos del tipo de las piracinas y analogos.
ES8301933A1 (es) "procedimiento para la preparacion de derivados de 4-(5)-alcohil-mercaptoimidazoles".
TR200102245T2 (tr) Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970724